trial · primary record
Caloric Restriction
Type2diabetes
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Rate of leucine oxidation in response to rising glucagon concentrations |
| Registry ID | NCT05499702 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:46.867Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05499702
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.